AQUABOUNTY TECHNOLOGIES INC AQB

Agriculture SIC 0900 - Fishing, Hunting and Trapping Nasdaq

AquaBounty has historically pursued a growth strategy that included the construction of large-scale recirculating aquaculture system ("RAS") farms for producing our genetically engineered Atlantic salmon (the "GE Atlantic salmon"). We had commenced construction of a 10,000 metric ton farm in Pioneer, Ohio (the "Ohio Farm Project"), but paused the construction in June 2023, as the cost estimate to complete the farm continued to substantially increase due to inflation and other factors. Further, these cost increases impaired our ability to pursue municipal bond financing, which was a necessary component of our funding strategy. We subsequently engaged an investment bank to pursue a range of funding and strategic alternatives, and to assist management in the prioritization of our core assets. These efforts resulted in the sale of our grow-out farm in Indiana ("Indiana Farm") in July 2024, recurring sales throughout 2024 and 2025 of selected equipment originally intended for the Ohio Farm Project ("Ohio Equipment Assets"), and the sale of our Canadian subsidiary, including the broodstock farms owned by the Canadian subsidiary in Prince Edward Island, Canada ("Canadian Farms"), and our intellectual property for the GE Atlantic salmon, along with trademarks and patents ("Corporate IP") in March 2025. After completion of these transactions, our primary remaining asset is our investment in the Ohio Farm Project, consisting of the remaining Ohio Equipment Assets and the land and construction in process (the "Ohio Farm Site"). We continue to work with an investment bank to identify the optimal path forward for realizing the potential of this asset, including its possible sale.

Last close 1.15 2026-09-04
Market cap $5.9M 2026-06-30 share count
52-week range 0.77 - 2.95

Valuation FY2025 figures against the last close

P/S
P/E
P/FCF
EV/EBITDA
Dividend yield
Diluted EPS-4.77

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $2.5M$3.1M$1.2M$127.7K$186.7K$84.5K$53.3K$0
Cost of revenue $3.6M$2.6M$1.2M$0
Gross profit -$3.4M-$2.5M-$1.1M$0
R&D $203.3K$506.2K$904.0K$2.1M$2.4M$2.4M$3.5M$3.4M$3.4M
SG&A $4.0M$9.0M$12.5M$9.8M$9.1M$6.8M$6.7M$4.1M$3.9M$3.8M
Total operating expenses $4.0M$9.6M$13.7M$25.5M$23.3M$16.4M$13.4M$10.5M$9.3M$8.1M
Operating income -$4.0M-$9.6M-$13.7M-$22.3M-$22.1M-$16.2M-$13.2M-$10.4M-$9.2M-$8.1M
Interest expense $206.1K$1.7M$235.0K$291.2K$316.4K$152.4K$63.0K$22.3K$21.5K$402.6K
Pre-tax income -$2.2M-$11.4M-$13.8M-$22.2M-$22.3M-$16.4M-$13.2M-$10.4M-$9.3M-$8.5M
Income tax $0$0$0$0$0$0$0$0$0
Net income -$18.5M-$149.2M-$27.6M-$22.2M-$22.3M-$16.4M-$13.2M-$10.4M-$9.3M-$8.5M
EPS, basic -4.77-38.65-7.17-5.78
EPS, diluted -4.77-38.65-7.17-5.78-0.32-0.45-0.66-0.94-1.06-1.60
Shares, diluted (wtd. avg.) $3.9M$3.9M$3.8M$3.8M$69.4M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $501.3K$230.4K$9.2M$102.6M$89.5M$96.3M$2.8M$3.0M$506.3K$3.3M
Short-term investments $101.8M
Receivables $855.9K$337.2K
Inventory $1.7M$2.3M$1.3M$1.5M$1.2M$76.1K$172.4K$0
Total current assets $10.3M$11.3M$31.0M$106.0M$193.0M$97.7M$4.5M$3.5M$1.4M$3.6M
Property, plant and equipment $22.7M$144.1M$106.3M$33.8M$26.9M$25.1M$23.7M$21.8M$1.7M
Other intangibles $204.4K$218.1K$231.8K$245.5K$157.6K$171.3K$185.0K$198.7K
Total assets $10.3M$34.1M$187.6M$213.8M$228.4M$125.8M$30.2M$27.7M$23.7M$5.7M
Accounts payable $337.0K$893.0K$12.1M$12.0M$4.3M$1.2M$809.4K$824.9K$2.7M$1.0M
Short-term debt $1.3M$524.5K$2.4M$627.4K$259.9K$163.2K$71.6K$49.8K$17.9K
Total current liabilities $8.7M$16.2M$14.8M$15.4M$5.9M$2.1M$1.7M$916.9K$2.7M$1.0M
Long-term debt $3.5M$2.0M$4.5M$6.3M$8.5M$8.5M$4.4M$3.5M$3.0M$2.6M
Total liabilities $12.2M$18.2M$22.5M$21.9M$14.6M$10.9M$6.5M$4.4M$5.8M$3.7M
Retained earnings -$388.3M-$369.8M-$220.6M-$193.0M-$170.9M-$148.5M-$132.1M-$118.9M-$108.5M-$99.3M
Total equity -$1.9M$15.8M$165.0M$191.9M$213.8M$114.9M$23.8M$23.2M$18.0M$2.0M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow -$8.7M-$13.9M-$24.2M-$21.0M-$20.5M-$14.3M-$11.2M-$9.8M-$9.1M-$7.4M
Depreciation and amortisation $904.1K$2.2M$2.0M$1.8M$1.5M$1.3M$843.4K$184.9K$154.0K
Stock-based compensation $70.6K$299.4K$542.3K$535.1K$394.2K$436.7K$872.2K$263.4K$122.1K$218.3K
Capital expenditure $2.9M$68.9M$67.5M$5.7M$4.0M$2.3M$4.0M$18.9M$934.5K
Investing cash flow $7.1M$7.6M-$68.9M$34.4M-$107.5M-$3.2M-$2.5M-$4.1M-$19.0M-$1.1M
Financing cash flow $1.9M-$2.7M-$308.5K-$162.4K$121.2M$111.0M$13.5M$16.4M$25.2M$10.5M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001603978-26-000056.